Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

24. Dezember 2024 05:01 ET | Quelle: Research and Markets

Myelodysplastic Syndrome (MDS) Drugs Market Trends and Sales Forecast to 2030: Total Revenues to Reach US$4.1 Billion Worldwide, with Immunomodulatory Drugs Dominating Shares

Dublin, Dec. 24, 2024 (GLOBE NEWSWIRE) -- The "Myelodysplastic Syndrome (MDS) Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
24. Januar 2024 13:33 ET | Quelle: Research and Markets

Myelodysplastic Syndrome Drugs Market Report 2024-2033 with Analysis of Key Trends Including Erythropoiesis-Stimulating Agents Optimization, Combination Therapies Integration, Emphasis on Iron Chelation Therapy

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Myelodysplastic Syndrome Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global myelodysplastic...
17. Juni 2021 07:58 ET | Quelle: Research and Markets

Global Myelodysplastic Syndrome Treatment Drugs Market (2021 to 2029) - Featuring Bayer, Celgene and Incyte Among Others

Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Myelodysplastic Syndrome (MDS) Treatment Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players,...